Iwona Olszok
Państwowa Wyższa Szkoła Zawodowa w Raciborzu(PL)
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Systemic Lupus Erythematosus Research, Vector-borne infectious diseases
Most-Cited Works
- → Effectiveness and safety of ledipasvir/sofosbuvir ± ribavirin in the treatment of HCV infection: The real-world HARVEST study(2017)28 cited
- → Prevalence of HCV genotypes in Poland – the EpiTer study(2016)24 cited
- → Efficacy of HCV treatment in Poland at the turn of the interferon era – the EpiTer study(2016)23 cited
- → Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis(2015)14 cited
- → P1169 EFFECT OF PEGYLATED INTERFERON OR RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR BASED THERAPY ON SVR12 IN NULL-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS (ADVEX STUDY)(2014)2 cited
- → 816 RIBAVIRIN DOSE REDUCTION DURING TELAPREVIR CONTAINING TRIPLE THERAPY DOES NOT AFFECT EARLY VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS WITH ADVANCED LIVER FIBROSIS(2013)1 cited
- [Ehrlichiosis].(2005)
- [Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)].(2011)
- awidność przeciwciał przeciwko Toxopls gondii - parametr przydatny w diagnostyce różnicowej antibodies against Toxoplasma gondii avidity - the useful parameter in the differential diagnostics(2009)